Related Experiment Video
Updated: May 23, 2026
09:48
An Orthotopic Endometrial Cancer Model with Retroperitoneal Lymphadenopathy Made From In Vivo Propagated and Cultured VX2 Cells
Published on: September 12, 2019
Locally recurrent endometrial cancer: a case report
Srinivas K Tantravahi1, Theresa L Werner
1Department of Medicine, Oncology Division, University of Utah Health Sciences Center and Huntsman Cancer Institute, Salt Lake City, Utah 84112, USA. srinivas.tantravahi@hci.utah.edu
Journal of the National Comprehensive Cancer Network : JNCCN
|April 12, 2012
Summary
Endometrial cancer, the most common female genital malignancy, is often diagnosed early. Treatment guidelines for its recurrence after hysterectomy are unclear, impacting clinical decisions.
Area of Science:
- Gynecologic Oncology
- Cancer Research
- Clinical Practice Guidelines
Background:
- Endometrial cancer is the most common female genital tract malignancy, typically affecting postmenopausal women.
- Early-stage diagnosis (75% of cases) is linked to better survival rates compared to many other cancers.
- Standard surgical staging involves total hysterectomy, bilateral salpingo-oophorectomy, and lymphadenectomy.
Observation:
- Adjuvant radiation therapy reduces locoregional recurrences in early-stage disease but does not improve overall survival.
- The efficacy of chemotherapy for early-stage endometrial cancer remains uncertain.
- Treatment for locoregional recurrence after hysterectomy is poorly defined, leading to clinical confusion.
Findings:
- Current guidelines for managing endometrial cancer recurrence are not specific, causing confusion among clinicians.
- A case report details a patient with stage IA endometrial cancer who experienced vaginal cuff recurrence 3 months post-surgery.
- This highlights the challenges in managing recurrent endometrial cancer.
Implications:
- There is a critical need for clearer, evidence-based guidelines for endometrial cancer recurrence management.
- Improved understanding and standardized protocols are essential for effective patient care and outcomes.
- Further research is warranted to establish optimal treatment strategies for recurrent endometrial cancer.
